Every parent wants to protect their baby — but what if the window to prevent lifelong allergies is smaller than anyone realized? Scientists have discovered that a newborn's immune system doesn't just work differently from an adult's; it's actually wired to overreact in ways that can set the stage for eczema and allergies before you even know it's happening. The culprit? A hormone, missing in babies, that keeps the immune system in check.

In this episode, Dr. Shruti Naik reveals what's really going on beneath your baby's skin, and what it could mean for the future of allergy prevention. If you like our podcast, please consider supporting it with a tax-deductible donation.

In Part 2 of our conversation with Dr. Peter Lio, we take an in-depth look at non-prescription eczema strategies, focusing on over-the-counter (OTC) innovations, microbiome re-balancing treatments, and "green space" therapy. Tune in to learn more about the latest-latest in options you can access on your own, without a doctor's prescription.

Links

Japanese study on green space and eczema risk: https://pubmed.ncbi.nlm.nih.gov/41942830/

Lemma Health OTC treatment comparison tool: https://lemmahealth.com/treatments/moisturizing-therapy-for-eczema

Join us for an enlightening conversation about existing, newly approved, and "coming soon" treatments for kids suffering from eczema -- from pills, to injections, to creams. In this two-part series, GPER's Executive Director interviews expert Dr. Peter Lio of the Chicago Integrative Eczema Center about the latest therapies for kids and explores how to choose between them ... and what's on the horizon based on news from the American Academy of Dermatology Annual Meeting. Learn more about how these treatments work and who they are best suited for in this 30-minute episode that is sure to offer insights -- and hope.

Further reading:

Atopic Dermatitis at AAD: Longer Dosing, Faster Itch Relief, and New Mechanisms

The GPER Treatment Navigator for Parents

Conflict of Interest Statements:

GPER has received sponsorships and grants from companies who develop treatments for eczema. These can be viewed at: www.gper.org/corporatecouncil